Is Pepto-Bismol Hypoallergenic? Salicylate Sensitivity, Not True Allergy
Pepto-Bismol is generally well-tolerated; true IgE allergy to bismuth subsalicylate is very rare and the alarming-sounding black tongue and black stool are harmless bismuth sulfide. The real clinical caveat is salicylate sensitivity โ aspirin-allergic patients and those with aspirin-exacerbated respiratory disease (AERD, Samter's triad) must avoid it because the drug shares the salicylate mechanism. Reye's syndrome risk also makes it contraindicated in children and teens with viral illness.
Free ยท 5 min ยท Insurance accepted
Key facts
True IgE allergy to bismuth subsalicylate is very rare; adverse reactions are from the salicylate mechanism โ COX-1 inhibition triggering pseudo-allergy in sensitive patients.
Pepto-Bismol is contraindicated in aspirin/NSAID-allergic patients and in AERD (aspirin-exacerbated respiratory disease), which affects approximately 7% of adult asthmatics.
Rajan JP et al. Journal of Allergy and Clinical Immunology. 2015;135(3):676-681.
Black tongue and black stool from Pepto-Bismol are harmless bismuth sulfide โ a benign chemical reaction that resolves within 1โ2 days of stopping the medication.
Salicylates including Pepto-Bismol carry a Reye's syndrome risk in children and teenagers during viral illness โ do not give to anyone under 18 with chickenpox or influenza.
CDC. Reye's syndrome. Centers for Disease Control and Prevention.
'Hypoallergenic' is a cosmetic-labeling term โ it does not apply to OTC drugs like Pepto-Bismol, which are governed by FDA drug monograph regulations.
What Is Pepto-Bismol and Is 'Hypoallergenic' Even a Meaningful Frame?
Pepto-Bismol (bismuth subsalicylate) is an OTC antidiarrheal and upset-stomach medication manufactured by Procter and Gamble.
It is available as a liquid (262 mg/15 mL) and as chewable tablets (262 mg per tablet). The active ingredient is bismuth subsalicylate โ a bismuth salt of salicylic acid โ which has antidiarrheal, antimicrobial, anti-inflammatory, and antacid properties.
The term 'hypoallergenic' is a cosmetic-labeling concept regulated under the FDA cosmetics framework; it does not apply to OTC drugs like Pepto-Bismol, which are governed by the FDA's drug monograph system (21 CFR Part 331 for antidiarrheals). Asking whether Pepto-Bismol is hypoallergenic is therefore a category error โ the appropriate reframe is: 'Is this OTC drug safe for me given my allergy history?'
For most adults without aspirin/NSAID sensitivity, Pepto-Bismol is well-tolerated and useful. The clinically important caveats are: the salicylate component contraindicated in aspirin-allergic and AERD patients, the Reye's syndrome risk in children and adolescents with viral illness, and the interaction profile with anticoagulants and tetracyclines. Black tongue and black stool โ the outcomes patients find most alarming โ are completely benign.
Symptoms of Pepto-Bismol Reactions
Recognizing symptoms early helps you get the right treatment faster.
Black tongue
mildHarmless dark discoloration of the tongue and mouth from bismuth sulfide formation โ alarming in appearance but completely benign and reversible.
Black stool
mildBismuth sulfide formation in the GI tract turns stool grey-black; benign and resolves within 1โ2 days of stopping the drug. Should be distinguished from iron deficiency or GI bleeding.
Constipation
mildDose-related reduction in bowel movements from the drug's antidiarrheal mechanism; resolves with stopping the medication.
Bronchospasm (AERD patients)
severeWheezing, chest tightness, and shortness of breath from salicylate-induced leukotriene overproduction in aspirin-sensitive asthmatics; may be severe โ seek urgent medical care.
Nasal congestion and rhinorrhea (AERD patients)
moderateAspirin-exacerbated nasal symptoms โ severe congestion, discharge โ from leukotriene overproduction; occurs in conjunction with or independently of bronchospasm.
Urticaria or angioedema (aspirin-sensitive patients)
severeHives or facial/tongue swelling from pharmacologic salicylate sensitivity โ not IgE-mediated but clinically indistinguishable from allergic urticaria; seek urgent medical care.
Reye's syndrome (children/teens with viral illness)
severeRare but severe hepatic and neurologic complication from salicylate use during viral illness in children and adolescents โ emergency: vomiting, confusion, altered behavior after Pepto-Bismol use during flu or chickenpox.
When to see a doctor
Symptoms from Pepto-Bismol divide clearly into benign expected effects, pharmacologic adverse reactions, and contraindicated-population reactions. Expected effects that alarm patients: black tongue (bismuth sulfide formation in the mouth after contact with trace sulfur-containing compounds), black stool (bismuth sulfide in the GI tract). Both are harmless, cosmetic, and resolve within 1โ2 days after stopping. No treatment is required. Constipation is a dose-related pharmacologic effect from the antidiarrheal action โ common and benign. Salicylate pseudo-allergy in aspirin-sensitive patients: bronchoconstriction, wheezing, nasal congestion, runny nose, urticaria, or angioedema occurring within minutes to hours of ingestion. Severity varies from mild to anaphylactoid. In AERD patients, respiratory symptoms dominate. These reactions are pharmacologic โ not IgE โ but can be severe. Reye's syndrome (children/teens with viral illness): vomiting, confusion, behavior changes, and liver dysfunction appearing days after salicylate use during viral illness. This is a medical emergency. Seek emergency care immediately for any child developing confusion, persistent vomiting, or altered behavior after taking Pepto-Bismol during a viral illness.
Pepto-Bismol and Asthma: The AERD Connection
The link between Pepto-Bismol and asthma is one of the most clinically important aspects of this drug. Aspirin-exacerbated respiratory disease (AERD) affects an estimated 7% of adult asthmatics and 14% of those with severe or difficult-to-control asthma (Rajan et al., J Allergy Clin Immunol, 2015). AERD is characterized by the triad of asthma, chronic sinusitis with nasal polyps, and intolerance to aspirin and other COX-1 inhibitors. Pepto-Bismol's salicylate component crosses the AERD threshold: it inhibits COX-1, shifts arachidonic acid toward leukotriene synthesis, and triggers the same bronchoconstriction and nasal symptoms as aspirin. Asthmatics with nasal polyps who have not been formally diagnosed with AERD should discuss salicylate tolerance with their allergist before taking Pepto-Bismol. Aspirin desensitization โ a specialized allergist-supervised protocol โ can render some AERD patients tolerant of aspirin and salicylates, but this is a clinical decision made under specialist supervision, not a self-managed option.
Complications of Pepto-Bismol in the Wrong Patient
In the appropriate patient, Pepto-Bismol has an excellent safety profile. Complications arise when it is used in contraindicated groups. In AERD patients, a salicylate-triggered bronchoconstriction can be severe enough to require emergency bronchodilator treatment or hospitalization. In aspirin-allergic patients with prior anaphylactoid reactions, Pepto-Bismol ingestion can precipitate urticaria, angioedema, or more severe systemic reactions. Reye's syndrome is the most severe potential complication, though it is now rare due to widespread awareness of the salicylate-viral illness interaction. Cases still occur when caregivers use Pepto-Bismol to treat nausea or stomach upset in children with undiagnosed influenza or early chickenpox. Drug interactions with warfarin are also a practical concern: the salicylate component's antiplatelet effect can potentiate anticoagulation and increase bleeding risk in patients on blood thinners.
Severe bronchospasm (AERD patients)
Salicylate-triggered leukotriene storm can cause serious acute bronchoconstriction requiring emergency bronchodilator treatment in poorly controlled or undiagnosed AERD patients.
Reye's syndrome (pediatric, viral illness)
Rare but potentially fatal hepatic and neurologic complication from salicylate use in children or adolescents during chickenpox or influenza โ absolutely contraindicated in this setting.
Drug interactions (warfarin, tetracyclines)
Salicylate component potentiates anticoagulants; bismuth chelates tetracycline antibiotics, reducing their efficacy โ both interactions require pharmacist or clinician guidance before use.
What Actually Causes Reactions to Pepto-Bismol?
Pepto-Bismol reactions almost always involve the salicylate component rather than true immunological allergy to bismuth. Bismuth subsalicylate delivers a salicylate dose to the gut comparable to a low-dose aspirin per standard serving. Patients with aspirin/NSAID allergy have pre-existing pharmacologic sensitivity to the COX-1 inhibition caused by salicylates โ the same mechanism that makes NSAIDs problematic.
How it works
The primary adverse reactions to Pepto-Bismol are pharmacologic, not immunologic. Bismuth subsalicylate releases salicylate in the gut, which inhibits cyclooxygenase-1 (COX-1), shifting arachidonic acid metabolism toward leukotrienes. In AERD patients, this leukotriene overproduction triggers bronchoconstriction and nasal congestion โ a pseudoallergic reaction mechanistically distinct from IgE-mediated allergy but clinically resembling an allergic attack. Black tongue and black stool result from bismuth reacting with trace sulfur in the gut to form bismuth sulfide โ a benign chemical reaction with no allergic or toxic significance.
Aspirin-exacerbated respiratory disease (AERD), also called Samter's triad, is the most important contraindicated condition. Patients with AERD have asthma, nasal polyps, and a pseudoallergic reaction to aspirin and other COX-1 inhibitors. Rajan et al. (J Allergy Clin Immunol, 2015) estimated AERD affects approximately 7% of all adult asthmatics and 14% of severe asthmatics. In AERD patients, salicylate ingestion โ including from Pepto-Bismol โ can trigger bronchoconstriction and nasal symptoms within minutes to hours, which can be severe.
The inactive ingredients (flavor, dyes, sweeteners in chewables) theoretically could cause IgE or contact reactions but are not documented sources of meaningful sensitization in the peer-reviewed literature. True IgE-mediated allergy to bismuth subsalicylate itself is essentially unreported. The reaction risk from Pepto-Bismol is pharmacologic, not immunologic.
Risk factors to watch for
Aspirin or NSAID allergy
Any documented allergy or intolerance to aspirin, ibuprofen, naproxen, or other NSAIDs is a contraindication to Pepto-Bismol because the salicylate component shares the COX-1 inhibition mechanism.
Aspirin-exacerbated respiratory disease (AERD)
AERD patients (asthma + nasal polyps + NSAID intolerance) face risk of bronchospasm and severe nasal symptoms from Pepto-Bismol's salicylate โ the reaction can be rapid and significant.
Children and adolescents with viral illness
Salicylates given during chickenpox or influenza are associated with Reye's syndrome โ a rare but severe hepatic and neurologic complication; Pepto-Bismol is absolutely contraindicated under 18 during viral illness.
Anticoagulant use
Pepto-Bismol's salicylate component can potentiate anticoagulants such as warfarin by its anti-platelet effect; patients on blood thinners should check with a pharmacist or clinician before using it.
Tetracycline antibiotic use
Bismuth chelates tetracycline antibiotics, reducing their absorption; concurrent use should be separated by at least 2 hours per prescribing guidance.
The Allergy Cascade
Exposure
Allergen contact
Detection
Immune recognition
IgE Response
Antibody production
Mast Cells
Histamine release
Symptoms
Allergic reaction
1.Exposure
Allergen contact
2.Detection
Immune recognition
3.IgE Response
Antibody production
4.Mast Cells
Histamine release
5.Symptoms
Allergic reaction
Diagnosing Reactions to Pepto-Bismol
Diagnosing a clinically significant reaction to Pepto-Bismol requires first distinguishing the expected from the unexpected. Black tongue, black stool, and constipation are expected effects โ they require no diagnostic workup and resolve with drug discontinuation. For suspected salicylate sensitivity (respiratory symptoms, urticaria, or angioedema after Pepto-Bismol), an allergist evaluation is the appropriate next step. The allergist will take a detailed NSAID reaction history and may perform an aspirin challenge under controlled conditions to confirm or exclude AERD or aspirin hypersensitivity. The NACDG standard series for contact allergens is not relevant here โ this is pharmacologic, not contact, sensitivity. Curex's at-home allergy testing is most useful in this context for patients who have concurrent environmental allergies and want to assess their overall atopic picture. Salicylate sensitivity is NOT an IgE-mediated allergy โ Curex's IgE panel cannot test for it. However, AERD patients frequently have concurrent IgE-mediated atopy (aeroallergens, mold), and an at-home IgE panel through services like Curex can characterize that concurrent sensitization while the patient pursues an AERD workup with their allergist.
Allergist Clinical History and NSAID Tolerance Assessment
A board-certified allergist takes a detailed history of NSAID reactions, respiratory symptoms with aspirin, and nasal polyp history to assess AERD probability before any challenge procedure.
Aspirin Challenge (Allergist-Supervised)
Oral or inhaled aspirin challenge with graded dosing under allergist supervision confirms or excludes aspirin hypersensitivity and AERD. Performed in a controlled clinical setting with rescue medication on hand.
Nasal Endoscopy and Polyp Assessment
ENT or allergist evaluation of nasal anatomy to identify polyps โ a key component of the AERD triad that influences clinical management and salicylate avoidance counseling.
Test from home with Curex
Skip the clinic visit. Curex sends an at-home allergy test kit to your door, and a board-certified allergist reviews your results to build a personalized treatment plan.
Take the allergy quizSafe Use and Alternatives for Pepto-Bismol
See how different approaches stack up for managing your allergy symptoms long-term.
For patients without contraindications, Pepto-Bismol is used as directed on the label for acute diarrhea, upset stomach, nausea, and heartburn. The black tongue and stool are cosmetic and self-limited โ no treatment modification is needed. Dose is as indicated by the product label without specific numeric doses per clinician guidance.
For contraindicated patients โ aspirin-allergic, AERD, children with viral illness โ the primary treatment is avoidance of Pepto-Bismol and substitution of a non-salicylate alternative. For acute diarrhea in these patients, loperamide (Imodium) is the appropriate non-salicylate OTC antidiarrheal โ it works through opioid receptor action in the gut rather than COX-1 inhibition and carries no salicylate sensitivity risk.
For AERD patients seeking long-term management, aspirin desensitization under allergist supervision can render some patients tolerant of aspirin and salicylates, enabling future use of these medications if clinically needed. This is a specialist-supervised procedure requiring clinic setting and monitoring.
Standard Use (Non-Contraindicated Patients)
Pepto-Bismol taken as directed on the label is appropriate for adults without aspirin/NSAID sensitivity. Expected cosmetic effects (black tongue, black stool) require no treatment and resolve spontaneously.
Bismuth subsalicylate (Pepto-Bismol) per label instructions
Effective for acute diarrhea, nausea, upset stomach, and heartburn in appropriate patients
Loperamide (for aspirin-sensitive patients)
Loperamide acts on opioid receptors in the gut to reduce intestinal motility โ a non-salicylate mechanism that is safe in aspirin-allergic and AERD patients for acute diarrhea management.
Loperamide (Imodium, generic)
Effective for acute diarrhea; clinical trials show symptom control comparable to bismuth subsalicylate for diarrhea predominant symptoms
Aspirin Desensitization (AERD patients, specialist only)
A graded aspirin challenge protocol administered by an allergist in a clinical setting gradually increases the patient's tolerance to aspirin and salicylates. Not for self-administration โ requires specialist supervision and monitoring.
Aspirin (graded dosing per specialist protocol)
Meta-analyses suggest 60โ70% of AERD patients achieve meaningful tolerance with maintained desensitization; also reduces nasal polyp burden in some patients
| Feature | Traditional | Allergy Shots (SCIT) | Immunotherapy (SLIT)Recommended |
|---|---|---|---|
| Treats root cause | No | Yes | Yes |
| Long-lasting relief | No | Yes | Yes |
| At-home treatment | Yes | No | Yes |
| No office visits | Yes | No | Yes |
| Low side effects | Yes | Partial | Yes |
| Estimated cost | Partial | Partial | Yes |
Traditional
- NoTreats root cause
- NoLong-lasting relief
- YesAt-home treatment
- YesNo office visits
- YesLow side effects
- PartialEstimated cost
Allergy Shots (SCIT)
- YesTreats root cause
- YesLong-lasting relief
- NoAt-home treatment
- NoNo office visits
- PartialLow side effects
- PartialEstimated cost
Immunotherapy (SLIT)
Recommended- YesTreats root cause
- YesLong-lasting relief
- YesAt-home treatment
- YesNo office visits
- YesLow side effects
- YesEstimated cost
Can Immunotherapy Help With Salicylate Sensitivity?
Instead of masking symptoms, immunotherapy retrains your immune system.
Salicylate sensitivity in AERD is a pharmacologic mechanism โ COX-1 inhibition shifting arachidonic acid metabolism โ not an IgE-mediated allergy. This means traditional allergen immunotherapy (shots or sublingual drops targeting IgE pathways) does not address salicylate pseudo-allergy. The specialist intervention for AERD is aspirin desensitization, which is distinct from allergy immunotherapy and must be performed under allergist supervision. However, AERD patients often have concurrent IgE-mediated atopy โ aeroallergen sensitization, mold allergy, and food allergy are common in this population. Treating those concurrent IgE allergies with immunotherapy can reduce the total allergic burden and sometimes improve AERD control. If you also have IgE-mediated respiratory allergies such as hay fever, dust mite asthma, or pet dander sensitivity, sublingual immunotherapy drops offered by providers like Curex with plan-specific pricing (https://getcurex.com/learn/curex-pricing) can address those separately and may reduce the overall inflammatory burden that drives AERD severity. In a real-world Curex study of 2,897 patients on at-home sublingual immunotherapy (Tharpe et al., Frontiers in Allergy, 2026), clinically meaningful symptom improvement rose to 45% of patients by two years, quality-of-life improvement reached 90.7%, and adherence was over 90% with no anaphylaxis reported. For the salicylate pseudo-allergy itself, the path is allergen avoidance plus aspirin desensitization if indicated โ not SLIT.
See an Allergist for AERD Evaluation
A board-certified allergist evaluates NSAID reaction history, nasal polyp status, and asthma control to confirm AERD and counsel on salicylate avoidance.
Avoid All Salicylate-Containing Products
Replace Pepto-Bismol with loperamide for diarrhea; avoid aspirin and NSAIDs; check OTC products for salicylate content (many topical analgesics contain methyl salicylate).
Consider Aspirin Desensitization if Appropriate
For AERD patients who need to take NSAIDs for other conditions or who have refractory nasal polyps, aspirin desensitization under allergist supervision may be indicated.
โAspirin desensitization achieves meaningful tolerance in approximately 60โ70% of AERD patients; concurrent IgE immunotherapy for aeroallergens can reduce total allergic burdenโ
Treat your Is Pepto-Bismol Hypoallergenic? Salicylate Sensitivity, Not True allergy at the source
See if at-home sublingual allergy drops fit your allergies โ a 2-minute quiz, designed by board-certified allergists, with no needles and no clinic visits.
- MD-ledBoard-certified allergists
- Plan-specificPricing ยท Confirm your quote
- 50K+Patients treated
- HSA/FSAEligible
Living With Salicylate Sensitivity
Aspirin/salicylate sensitivity requires vigilance beyond Pepto-Bismol โ the same pharmacologic mechanism is shared by aspirin, ibuprofen, naproxen, many other NSAIDs, and topical products containing methyl salicylate (some muscle rubs, liniments, and sports creams). Patients with documented AERD need to carry a list of salicylate-containing medications to share with any healthcare provider and to read OTC medication labels carefully. The reassuring message is that salicylate-free alternatives exist for most common indications: acetaminophen (Tylenol) for pain and fever, loperamide for diarrhea, and non-salicylate antacids for stomach upset. AERD is manageable โ most patients can live well with identified trigger avoidance and appropriate specialist follow-up.
Aspirin-Allergic? Pepto-Bismol Is Contraindicated
Pepto-Bismol contains the salicylate that triggers your allergy. Use loperamide for diarrhea and acetaminophen for pain. Inform all healthcare providers about your aspirin allergy.
Black Tongue and Stool: Completely Harmless
Bismuth sulfide formation creates dark discoloration that alarms patients. It is a cosmetic effect with no health significance and resolves within 1โ2 days of stopping the drug.
Children and Teens: Never During Viral Illness
Reye's syndrome from salicylates during chickenpox or influenza is a pediatric emergency. Use acetaminophen or ibuprofen (appropriate age group) โ never Pepto-Bismol โ for children with viral illness symptoms.
Check Topical Products Too
Methyl salicylate in muscle rubs and some sports creams can be absorbed through skin at therapeutically relevant concentrations โ aspirin-sensitive patients should also avoid these topical salicylates.
When Is Pepto-Bismol Risk Relevant?
Pepto-Bismol risk is not seasonal in the traditional allergy sense โ salicylate sensitivity is a year-round pharmacologic characteristic. However, the Reye's syndrome risk has a seasonal correlate: influenza and chickenpox peak in winter and spring respectively, making those the highest-risk periods for salicylate administration in children during viral illness. AERD patients may notice that their salicylate sensitivity correlates with nasal polyp burden โ which can fluctuate seasonally with concurrent airborne allergen exposure โ but this is a secondary modulating factor rather than a true seasonal pattern. Pepto-Bismol should be avoided year-round in all contraindicated patient groups.
January - December
medium intensity
Preventing Pepto-Bismol Reactions
Prevention of Pepto-Bismol reactions in the contraindicated groups is straightforward: identify your risk before use. Aspirin or NSAID allergy means avoid Pepto-Bismol. Asthma plus nasal polyps โ even without a formal AERD diagnosis โ means consult an allergist before taking any salicylate-containing medication. Children and adolescents with any viral illness should never receive Pepto-Bismol. For patients on warfarin, NSAIDs, or tetracycline antibiotics, pharmacist consultation before any new OTC medication including Pepto-Bismol is the standard precaution. Reading the 'Do Not Use' and 'Ask a Doctor or Pharmacist' sections of the Pepto-Bismol label provides the same guidance โ it explicitly contraindicts use in aspirin-allergic patients and in children under 12.
Aspirin-Allergic? Skip Pepto-Bismol Entirely
Any documented aspirin or NSAID allergy or intolerance means Pepto-Bismol is contraindicated โ the salicylate mechanism is the same. Use loperamide instead.
Asthma + Nasal Polyps: Consult an Allergist First
This combination suggests possible AERD โ an allergist evaluation before taking salicylate-containing medications is the prudent step.
Never Give to Children or Teens With Viral Illness
Reye's syndrome risk from salicylates in viral illness (chickenpox, influenza) is an absolute contraindication โ use only non-salicylate alternatives for GI symptoms in this population.
Black Tongue and Stool: No Action Needed
Bismuth sulfide formation causing black discoloration is a harmless expected effect โ no dose change, doctor visit, or product switch is required.
Outlook for Pepto-Bismol and Salicylate Sensitivity
For patients without salicylate sensitivity, Pepto-Bismol is a safe and effective OTC medication with excellent outcomes for its indicated uses. Black tongue and stool resolve without intervention. For AERD patients, lifelong salicylate avoidance is effective at preventing acute reactions โ but AERD itself requires ongoing specialist management for the underlying asthma and nasal polyp disease. Aspirin desensitization, where appropriate, offers meaningful long-term benefit. The prognosis of AERD overall has improved substantially with the availability of biologic therapies for asthma and nasal polyps.
Key takeaways
True IgE allergy to bismuth subsalicylate is very rare; adverse reactions are pharmacologic (salicylate mechanism) not immunologic
Black tongue and black stool are benign bismuth sulfide effects โ no clinical action required
AERD patients and aspirin-allergic individuals must avoid Pepto-Bismol; loperamide is the appropriate non-salicylate antidiarrheal substitute
Diet and Salicylate Sensitivity
For patients with confirmed salicylate sensitivity (AERD or aspirin allergy), dietary salicylates are a consideration but are generally at concentrations far below the pharmacologic thresholds of aspirin or Pepto-Bismol. Some AERD patients โ particularly those with severe disease โ may benefit from a low-salicylate diet under dietitian guidance, avoiding high-salicylate foods such as berries, mint, tomato sauce, and certain spices. This is a specialist-guided intervention for refractory AERD, not a general recommendation. Most salicylate-sensitive patients tolerate typical dietary salicylate concentrations without triggering AERD symptoms.
Foods to limit
High-salicylate foods (for confirmed severe AERD only)
Berries, mint, tomatoes, dried fruits, and certain spices contain dietary salicylates that may accumulate above threshold in severely sensitive AERD patients โ specialist dietitian guidance required.
Pepto-Bismol is not really an allergy question โ it is a salicylate question. Anyone who can't take aspirin shouldn't take Pepto either, and that includes patients with aspirin-exacerbated respiratory disease, where the reaction is asthma and nasal symptoms, not hives. The black tongue and black stool people worry about are completely benign.
Frequently Asked Questions
No. Pepto-Bismol's active ingredient, bismuth subsalicylate, contains a salicylate โ the same chemical class that aspirin belongs to. Patients with documented aspirin allergy or NSAID intolerance can experience the same reaction pattern from Pepto-Bismol as from aspirin itself: urticaria, bronchospasm, angioedema, or anaphylactoid reactions depending on their sensitivity profile. The drug label explicitly lists aspirin allergy as a contraindication. For diarrhea or stomach upset, loperamide (Imodium) is a safe non-salicylate alternative. Consult your pharmacist or allergist before using any OTC medication if you have a documented aspirin or NSAID allergy.
Medical References
- [1]StatPearls. Bismuth Subsalicylate. NCBI Bookshelf, NBK560697. National Library of Medicine.
- [2]Rajan JP, Wineinger NE, Stevenson DD, White AA. Prevalence of aspirin-exacerbated respiratory disease among asthmatic patients: a meta-analysis of the literature. Journal of Allergy and Clinical Immunology. 2015;135(3):676-681.
- [3]White AA, Stevenson DD. Aspirin-exacerbated respiratory disease. New England Journal of Medicine. 2018;379(11):1060-1070.
- [4]CDC. Reye's syndrome. Centers for Disease Control and Prevention.
- [5]Pepto-Bismol. Prescribing information and patient labeling. Procter and Gamble / DailyMed NLM.
- [6]FDA. Hypoallergenic cosmetics. U.S. Food and Drug Administration. fda.gov.
- [7]Tharpe C, et al. Real-world outcomes of personalized sublingual immunotherapy for environmental allergies delivered through a telemedicine platform. Frontiers in Allergy. 2026;7:1865860.
- [8]Schaffer FM, Naples AR, Ebeling M, Hulsey TC, Garner LM. The safety of self-administered allergen immunotherapy during the buildup and maintenance phases. Int Forum Allergy Rhinol. 2015;5(2):149-156.
This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about a medical condition. Content reviewed by board-certified allergists at Curex.
Ready to treat your Is Pepto-Bismol Hypoallergenic? Salicylate Sensitivity, Not True allergies for good?
Get a personalized treatment plan from board-certified allergists, delivered to your door.
Reviewed by board-certified allergists. Personalized treatment plans based on your at-home IgE test, not generic protocols.
Compare Curex plan pricingQuestions about Curex itself?
Straight answers about the company, the evidence, what patients report, and what it costs โ including the parts that are not flattering.
